VRTX
$VRTX
Vertex Pharmaceuticals
Biotech leader in cystic fibrosis treatments and pain therapies.
Healthcare$458.05
+6.46 (+1.43%)
Day Range$449.75 - $459.45
Prev Close$451.59
Subscribers
0
Tracking this ticker
Next Report
Sun, Mar 22
Weekly updates
Latest Report
VRTX: Pipeline Momentum and Valuation Check
Vertex ($VRTX) is showing renewed momentum after positive Phase 3 readouts in kidney and pain, and analysts remain bullish. The stock trades below recent highs, leaving room for upside, but valuation and execution risk remain.
Mar 16, 2026